Jupiter Neurosciences Secures 3-Month Extension on Convertible Note Payments

summarizeSummary

Jupiter Neurosciences amended its $6.0 million convertible notes, delaying monthly payments by three months and revising the payment schedule, providing immediate liquidity relief.

check_boxKey Events

• Convertible Note Amendment

  The company entered into an Omnibus Amendment with YA II PN, LTD, modifying the terms of its $6.0 million convertible promissory notes.

• Payment Extension Granted

  Monthly installment payments for the convertible notes will now commence on April 1, 2026, an extension of approximately three months from the previous schedule.

• Revised Payment Schedule

  The amendment introduces a variable payment schedule for the notes and updates provisions related to Advance Notices under the Standby Equity Purchase Agreement (SEPA).

• Enhanced Financial Flexibility

  This extension provides Jupiter Neurosciences with additional time and flexibility in managing its cash flow and debt obligations.

auto_awesomeAnalysis

Jupiter Neurosciences, a life sciences company, has amended its existing $6.0 million convertible promissory notes with Yorkville, pushing back the start of monthly installment payments by approximately three months to April 1, 2026. This provides the company with crucial short-term financial flexibility and extends its cash runway, which is particularly important for a small-cap biotech firm managing development costs. The amendment also introduces a variable payment schedule and clarifies how proceeds from future equity sales under the Standby Equity Purchase Agreement (SEPA) will be allocated, with 50% potentially used to prepay future installments.